76 related articles for article (PubMed ID: 9587496)
1. [Immunobiology of tolerance of hepatic allografts: to what degree can the immunosuppressive treatment be avoided?].
Borie DC; Calmus Y; Boleslawski E; Hannoun L
Gastroenterol Clin Biol; 1997; 21(8-9):584-9. PubMed ID: 9587496
[No Abstract] [Full Text] [Related]
2. [Tolerance of hepatic allografts].
Calmus Y; Weill B; Amar I; Houssin D
Gastroenterol Clin Biol; 1986 Dec; 10(12):804-16. PubMed ID: 3542688
[No Abstract] [Full Text] [Related]
3. A short course of cyclosporine immunosuppression inhibits rejection but not tolerance of rat liver allografts.
Huang WH; Yan Y; De Boer B; Bishop GA; House AK
Transplantation; 2003 Feb; 75(3):368-74. PubMed ID: 12589161
[TBL] [Abstract][Full Text] [Related]
4. Unique aspects of rejection and tolerance in liver transplantation.
Knechtle SJ; Kwun J
Semin Liver Dis; 2009 Feb; 29(1):91-101. PubMed ID: 19235662
[TBL] [Abstract][Full Text] [Related]
5. [Immunologic study of the tolerance of hepatic allografts in rats].
Farges O
Ann Chir; 1989; 43(6):503-5. PubMed ID: 2817749
[No Abstract] [Full Text] [Related]
6. Immune activation is required for the induction of liver allograft tolerance: implications for immunosuppressive therapy.
Bishop GA; McCaughan GW
Liver Transpl; 2001 Mar; 7(3):161-72. PubMed ID: 11244155
[TBL] [Abstract][Full Text] [Related]
7. [Tolerance to hepatic allografts].
Houssin D; Pla M
Presse Med; 1984 Jul; 13(28):1734-8. PubMed ID: 6235491
[TBL] [Abstract][Full Text] [Related]
8. Effects of combined immune therapy on survival and Th1/Th2 cytokine balance in rat orthotopic liver transplantation.
Cao H; Liu H; Wu ZY
Chin Med J (Engl); 2007 Oct; 120(20):1809-12. PubMed ID: 18028776
[TBL] [Abstract][Full Text] [Related]
9. 1 alpha,25-Dihydroxycholecalciferol reduces rejection and improves survival in rat liver allografts.
Redaelli CA; Wagner M; Tien YH; Mazzucchelli L; Stahel PF; Schilling MK; Dufour JF
Hepatology; 2001 Nov; 34(5):926-34. PubMed ID: 11679963
[TBL] [Abstract][Full Text] [Related]
10. Tacrolimus-based partial conditioning produces stable mixed lymphohematopoietic chimerism and tolerance for cardiac allografts.
Gammie JS; Li S; Zeevi A; Demetris AJ; Ildstad ST; Pham SM
Circulation; 1998 Nov; 98(19 Suppl):II163-8; discussion II168-9. PubMed ID: 9852899
[TBL] [Abstract][Full Text] [Related]
11. Advances in immune-based therapies to improve solid organ graft survival.
Rose SM; Turka L; Kerr L; Rotrosen D
Adv Intern Med; 2001; 47():293-331. PubMed ID: 11795079
[No Abstract] [Full Text] [Related]
12. Can we selectively shut off immune responses?
Cohen J
Science; 2005 Jul; 309(5731):97. PubMed ID: 15994543
[No Abstract] [Full Text] [Related]
13. Viral hepatitis after liver transplantation. Which immunosuppressive drugs should be recommended?
Ciesek S; Manns MP; Wedemeyer H
Minerva Gastroenterol Dietol; 2007 Dec; 53(4):337-50. PubMed ID: 18043552
[TBL] [Abstract][Full Text] [Related]
14. Exploiting tolerance processes in transplantation.
Waldmann H; Cobbold S
Science; 2004 Jul; 305(5681):209-12. PubMed ID: 15247471
[TBL] [Abstract][Full Text] [Related]
15. Transplantation for the millennium: attaining tolerance in our time--the Holy Grail.
Helderman JH; Goral S
Semin Nephrol; 2000 Jan; 20(1):83-6. PubMed ID: 10651221
[TBL] [Abstract][Full Text] [Related]
16. The protective effect of the liver: does it apply to the bowel too?
Pirenne J; Kawai M
Transplantation; 2006 Apr; 81(7):978-9. PubMed ID: 16612270
[No Abstract] [Full Text] [Related]
17. How can we measure immunologic tolerance in humans?
Najafian N; Albin MJ; Newell KA
J Am Soc Nephrol; 2006 Oct; 17(10):2652-63. PubMed ID: 16928808
[TBL] [Abstract][Full Text] [Related]
18. Immunological tolerance--the liver effect.
Calne RY
Immunol Rev; 2000 Apr; 174():280-2. PubMed ID: 10807523
[TBL] [Abstract][Full Text] [Related]
19. New aspect of immunosuppressive treatment in liver transplantation. How could you induce tolerance in liver transplantation?
Beaudreuil S; Samuel D; Rouas-Freiss N; Durrbach A
Transpl Immunol; 2007 Feb; 17(2):98-107. PubMed ID: 17306740
[TBL] [Abstract][Full Text] [Related]
20. Is there a customised immunosuppressive regimen for patients transplanted with hepatocellular carcinoma?
Majno P; Giostra E; Mentha G;
J Hepatol; 2005 Oct; 43(4):577-84. PubMed ID: 16118027
[No Abstract] [Full Text] [Related]
[Next] [New Search]
